Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment

Cell Reports(2022)10.1016/j.celrep.2022.111201Source: DataRank Database

Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access34 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: goldTopics (39)Linked Datasets (20)DataCite Reuse (20)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Gauri Deb ORCID,Alexander Cicala ORCID,Adam Officer ORCID,Chelsea Hope,Adam Pagenkopf ORCID

Live enrichment

PubMed:35977482

Leukemia and Lymphoma Society

Grant: 6551-18

University of California, San Diego

Grant: P30CA014520

American Cancer Society

Grant: 127508-RSG-15-045-01-LIB

National Cancer Institute

Grant: R01CA230275

National Cancer Institute

Grant: R01CA252937

National Cancer Institute

Grant: U01CA196406

U.S. National Library of Medicine

Grant: T15LM011271

National Institutes of Health

Grant: 1R01CA252937-01

Tumor matrix remodeling in anti-myeloma immunity and immunotherapy

National Institutes of Health

Grant: 5U01CA196406-04

Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers

National Institutes of Health

Grant: 2T15LM011271-11

San Diego Biomedical Informatics Education & Research (SABER)

National Institutes of Health

Grant: 5R01CA230275-04

Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation

National Institutes of Health

Grant: 5P30CA014520-18

CANCER CENTER SUPPORT

goldLicense: CC BY NC ND

publisherhttps://doi.org/10.1016/j.celrep.2022.111201

publisherhttps://api.elsevier.com/content/article/PII:S221112472201018X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S221112472201018X?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9402878

https://pubmed.ncbi.nlm.nih.gov/35977482

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciencesCD8-Positive T-LymphocytesDendritic CellsHumansImmunity, InnateLymphocytesNeoplasmsTumor MicroenvironmentVersicans

MeSH Terms

CD8-Positive T-LymphocytesDendritic CellsHumansImmunity, InnateLymphocytesNeoplasmsTumor MicroenvironmentVersicans

Keywords

VersicansNeoplasmsTumor MicroenvironmentHumansDendritic CellsLymphocytesCD8-Positive T-LymphocytesArticleImmunity, InnateCD40CP: CancerCP: ImmunologycDC1checkpoint inhibitorsimmunotherapyproteoglycanstumor matrixtumor stromaversicanversikine

Additional file 9 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700672.v1figshare

Additional file 6 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700663figshare

Additional file 1 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700648.v1figshare

Additional file 2 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700651figshare

Additional file 7 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700666.v1figshare

Additional file 6 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700663.v1figshare

Additional file 8 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700669figshare

Additional file 5 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700660.v1figshare

Additional file 4 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700657.v1figshare

Additional file 5 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700660figshare

Additional file 9 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700672figshare

Additional file 10 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700675.v1figshare

Additional file 1 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700648figshare

Additional file 8 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700669.v1figshare

Additional file 10 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700675figshare

Additional file 2 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700651.v1figshare

Additional file 7 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700666figshare

Additional file 4 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700657figshare

Additional file 3 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700654.v1figshare

Additional file 3 of TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells

10.6084/m9.figshare.23700654figshare

Related Papers (10)

Immunometabolism in the tumor microenvironment and its related research progress

Frontiers in Oncology(2022)

OpenAlex related

10.3389/fonc.2022.1024789

Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia

Open Access Macedonian Journal of Medical Sciences(2017)

OpenAlex related

10.3889/oamjms.2017.151

Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate.

Endocrinology(1992)

OpenAlex related

10.1210/endo.130.5.1374018

Functional characterization of two stromal cell lines that support B lymphopoiesis.

The Journal of Immunology(1990)

OpenAlex related

10.4049/jimmunol.145.2.423

Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.

The Journal of Clinical Endocrinology & Metabolism(1996)

OpenAlex related

10.1210/jcem.81.2.8636277

STUDIES ON THE MECHANISMS FOR ACTION OF FIBROBLAST GROWTH FACTORS IN STROMAL CELLS OF HYPERPLASTIC HUMAN PROSTATE

The Japanese Journal of Urology(1995)

OpenAlex related

10.5980/jpnjurol1989.86.1034

A COMPARATIVE HISTOCHEMICAL STUDY OF THE OVARIAN STROMAL LIPID BAND, STROMAL THECA CELL, AND NORMAL OVARIAN FOLLICULAR APPARATUS

Obstetrical & Gynecological Survey(1966)

OpenAlex related

10.1097/00006254-196602000-00012

[Effect of prostate peripheral zones stromal cells on the proliferation of prostate cells by overexpression of LMO2 gene].

PubMed(2016)

OpenAlex related

10.3760/cma.j.issn.0376-2491.2016.02.003

Targeting stromal-derived Gremlin1 to control Multiple Myeloma disease development

Clinical Lymphoma Myeloma & Leukemia(2019)

OpenAlex related

10.1016/j.clml.2019.09.242

Classification of muscle-invasive bladder cancer based on tumor stromal compartment

Research Square (Research Square)(2020)

OpenAlex related

10.21203/rs.2.21225/v1